Scarica l'app Stockscreener
24.81
3.03%
0.73
Precedente Chiudi:
$24.08
Aprire:
$24.08
Volume 24 ore:
13,240
Relative Volume:
0.61
Capitalizzazione di mercato:
$69.11M
Reddito:
$23.93M
Utile/perdita netta:
$-3.41M
Rapporto P/E:
-21.76
EPS:
-1.14
Flusso di cassa netto:
$-33.87M
1 W Prestazione:
-11.27%
1M Prestazione:
+62.69%
6M Prestazione:
+310.83%
1 anno Prestazione:
+293.81%
Intervallo 1D:
$23.22
$24.85
Intervallo di 1 settimana:
$23.13
$28.97
Portata 52W:
$4.006
$30.00
Sol Gel Technologies Ltd Stock (SLGL) Company Profile
Nome
Sol Gel Technologies Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Confronta SLGL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SLGL
Sol Gel Technologies Ltd
|
24.81 | 66.72M | 23.93M | -3.41M | -33.87M | -1.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Sol Gel Technologies Ltd Stock (SLGL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-19 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2022-10-21 | Ripresa | Jefferies | Hold |
| 2019-12-31 | Reiterato | H.C. Wainwright | Buy |
| 2019-12-31 | Reiterato | JMP Securities | Mkt Outperform |
Sol Gel Technologies Ltd Borsa (SLGL) Ultime notizie
Identifying reversal signals in Sol Gel Technologies Ltd.Earnings Trend Report & High Conviction Investment Ideas - Newser
How to interpret RSI for Sol Gel Technologies Ltd. stockQuarterly Market Summary & Verified Momentum Stock Alerts - Newser
How to monitor Sol Gel Technologies Ltd. with trend dashboardsInflation Watch & Community Shared Stock Ideas - Newser
Will Sol Gel Technologies Ltd. stock go up soonQuarterly Investment Review & Real-Time Market Sentiment Alerts - Newser
How to integrate Sol Gel Technologies Ltd. into portfolio analysis toolsWeekly Profit Report & Low Drawdown Investment Ideas - Newser
How to track smart money flows in Sol Gel Technologies Ltd.2025 Valuation Update & Weekly Breakout Watchlists - Newser
Order flow analysis tools used on Sol Gel Technologies Ltd.July 2025 Short Interest & Accurate Buy Signal Alerts - Newser
Is Sol Gel Technologies Ltd. stock bottoming outJuly 2025 Retail & Safe Swing Trade Setups - Newser
Key resistance and support levels for Sol Gel Technologies Ltd.Weekly Trading Summary & Risk Managed Investment Strategies - Newser
Applying Elliott Wave Theory to Sol Gel Technologies Ltd.Dollar Strength & Free Reliable Trade Execution Plans - Newser
Using R and stats models for Sol Gel Technologies Ltd. forecasting2025 Bull vs Bear & Safe Capital Growth Tips - Newser
What does recent volatility data suggest for Sol Gel Technologies Ltd.2025 Winners & Losers & Weekly Setup with High ROI Potential - Newser
Can swing trading help recover from Sol Gel Technologies Ltd. losses2025 Earnings Impact & Consistent Return Investment Signals - Newser
Short Interest in Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Drops By 36.6% - MarketBeat
News impact scoring models applied to Sol Gel Technologies Ltd.Market Sentiment Summary & AI Optimized Trading Strategy Guides - Newser
Published on: 2025-09-11 17:27:04 - Newser
Sol-Gel Technologies Secures Health Canada Approval for EPSOLAY - MSN
Will Sol Gel Technologies Ltd. continue its uptrendAnalyst Downgrade & Low Risk Profit Maximizing Plans - Newser
Market reaction to Sol Gel Technologies Ltd.’s recent newsTrade Risk Report & Community Consensus Stock Picks - Newser
Volume spikes in Sol Gel Technologies Ltd. stock – what they meanChart Signals & AI Enhanced Market Trend Forecasts - Newser
What to do if you’re stuck in Sol Gel Technologies Ltd.Market Weekly Review & Verified Chart Pattern Trade Signals - Newser
Basal Cell Neoplasms Clinical Trial Pipeline Accelerates as 22+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - GlobeNewswire Inc.
Will Sol Gel Technologies Ltd. stock recover after recent dropEarnings Beat & Reliable Trade Execution Plans - Newser
Using economic indicators to assess Sol Gel Technologies Ltd. potentialShare Buyback & AI Powered Market Entry Strategies - Newser
Is Sol Gel Technologies Ltd. trending in predictive chart models2025 Retail Activity & Free Accurate Trade Setup Notifications - Newser
How to escape a deep drawdown in Sol Gel Technologies Ltd.July 2025 Chart Watch & Low Drawdown Momentum Trade Ideas - Newser
Sentiment analysis tools applied to Sol Gel Technologies Ltd.Portfolio Risk Report & Weekly High Conviction Trade Ideas - Newser
Chart overlay techniques for tracking Sol Gel Technologies Ltd.Market Growth Report & High Conviction Investment Ideas - Newser
Best data tools to analyze Sol Gel Technologies Ltd. stock2025 Retail Activity & Reliable Volume Spike Trade Alerts - Newser
Using Bollinger Bands to evaluate Sol Gel Technologies Ltd.Earnings Trend Report & Weekly High Return Forecasts - Newser
Does Sol Gel Technologies Ltd. have strong EBITDA margins2025 Pullback Review & Weekly Top Performers Watchlists - Lancaster City Council
Can Sol Gel Technologies Ltd. outperform in the next rally2025 Bull vs Bear & Free Community Consensus Stock Picks - Lancaster City Council
Sol Gel Technologies Ltd Azioni (SLGL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.93%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):